AIDS in developing countries is a threeat to the globe as 95% of the AIDS victims dwell in here. In the United Nations General Assembly Special
AIDS in developing countries is a threeat to the globe as 95% of the AIDS victims dwell in here. In the United Nations General Assembly Special Session on HIV/AIDS, physicians demanded to bring down the cost of anti retroviral therapy that would cater the AIDS victims in developing countries.
Dr. Anne-Valerie Kaninda, medical advisor for Doctors without borders (commonly known as Medicines Sans Frontieres, or MSF), MSF provides healthcare assistance in 18 countries that are overburdened with infectious disease, war and disasters, came out with the point that these 34 million people in developing countries cannot be abondoned the treatment just because of the cost of these drugs.Dr. Kaninda, at an MSF-sponsored panel discussion pointed that expensive antiretroviral therapies - are primarily the privilege of a small minority of patients living in a handful of rich countries while a large majority of HIV victims are from developing world.
Speakers at the meeting focused onto deliver HIV/AIDS care in a countries, including the Ukraine, Thailand, Kenya and Cameroon. They variously noted that abject poverty, government indifference and corruption, lack of public education and cultural taboos and stigma contribute to raise in the infection rate and lack of resources. Unanimousity established over the fact that main culprit has been the astronomic price of cutting-edge antiretroviral medications.
Dr. Chris Ouma of the AIDS treatment organization Action Aid Kenya "Our people have families, homes, feelings, aspirations and jobs. But unfortunately their income is such that they are not able to afford the drugs they need. So I really don't think respecting the monopoly of a drug company in the face of AIDS is a good argument. AIDS is unique and I think we have to draw a line."
